FDA Inspection
Central California Blood CenterCentral California Blood Center – FDA Inspection, Sep 26, 2019
Record Details
This FDA Inspection record concerns Central California Blood Center, with an inspection on September 26, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · b4cf0b2c-d124-4d73-9f6c-e14a5983879b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102983
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Central California Blood Center
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 29, 2025 | VAI | San Francisco District Office | Blood and Blood Products |
| September 9, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 7, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 1, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Central California Blood Center
- FDA Inspection 1280315 - 2025-08-29
- FDA Inspection 984040 - 2016-09-09
- FDA Inspection 867390 - 2014-03-07
- FDA Inspection 771722 - 2012-02-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.